July 16th 2025, 7:20pm
By Ryan Scott
Food insecurity is linked to a 28% higher risk of death among cancer survivors compared with those who have never received a cancer diagnosis, a new study found.
July 16th 2025, 5:08pm
Dr. Olalekan O. Oluwole explained how CAR T is used to treat high-risk blood cancers and highlighted the potential of outpatient CAR T-cell therapy treatment.
July 16th 2025, 4:00pm
By John Smelcer, PhD, CAGS
Writing poems following my lymphoma diagnosis gave me hope and purpose as I endured chemo, helping me heal and share my experience with others.
July 16th 2025, 3:00pm
By Spencer Feldman
Carotuximab plus Erleada proved safe in the first 10 patients with metastatic castration-resistant prostate cancer dosed on the phase 2 trial.
July 16th 2025, 1:00pm
By Olalekan O. Oluwole
Outpatient CAR T therapy has reduced hospital stays by two-thirds while maintaining safety for those with blood cancers, according to Dr. Olalekan Oluwole.
July 15th 2025, 9:00pm
By Chaipat Tirapongprasert
Facing leukemia and uncertainty, I leaned on love and resolve to keep living day by day, despite fear and an unknown future ahead.
July 15th 2025, 8:00pm
By Dr. Masey Ross
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
July 15th 2025, 6:59pm
Dr. Breelyn Wilky discusses challenges that patients with GIST face and shares advice with those who feel overwhelmed by the rarity of their condition.
July 15th 2025, 5:08pm
Dr. Vincent Ma discussed the most recent and notable treatment updates for patients with high-risk and advanced melanoma.
July 15th 2025, 4:00pm
By Laura Yeager
Laura Yeager is a two-time breast cancer survivor. Catch up on all of Laura's blogs here!
July 15th 2025, 3:00pm
Bria-IMT plus a checkpoint inhibitor improved survival versus Trodelvy and chemo in patients with heavily pretreated metastatic breast cancer.
July 15th 2025, 1:50pm
By Amrita Krishnan, MD
Panelists discuss the multifaceted diagnostic process for multiple myeloma, emphasizing the integration of blood tests, genetic and imaging assessments, and patient education to guide personalized treatment planning and enhance patient engagement in care.
July 15th 2025, 1:43pm
The program emphasized the importance of incorporating patient and caregiver perspectives alongside clinical expertise to support personalized, empathetic care and shared decision-making in managing the diverse and complex challenges of multiple myeloma.
July 15th 2025, 1:00pm
By Dr. Paolo Tarantino
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
July 14th 2025, 9:00pm
By Linda Cohen
I’m in remission from small lymphocytic lymphoma and off treatment, savoring this break while learning to live with the uncertainty that still lingers.
Top Lung Cancer Stories from October: Insights, and Patient Journeys
How AI Can Put Patients at the Center of Cancer Care
FDA Approves Darzalex Faspro in High-Risk Smoldering Multiple Myeloma
Sharing More Than 25 Years of Brain Tumor Survival